Interesting clocking in & reading the various...

Interesting clocking in & reading the various reactions.

Personally, I'm grateful for the confirmation as removing any doubt, both to shareholders & any other interested parties. JM's post says it all for most of us, on the evidence of the number of ticks - 'Today's announcement finally tells us Esra has something she is confident that can go the whole way.'

I'm a little surprised that nobody has highlighted the last sentence of the notice, viz. 'Phosphagenics is now actively planning all aspects of the clinical program to enable the Company to maximise the commercialisation potential of the patch portfolio.' To me it not only emphasises JM's point, but publically & actively flaunts the Company's technology in the open market. Come & woo us, suitors?

Purely a personal thought, of course.